GMED R&D Expense Growth
Globus Medical, Inc. Class A Common Stock · R&D Expense Growth
GMED R&D Expense Growth
Latest reported12.97%period ending
GMED FY R&D Growth (YoY) (0.00% → 12.97%)
Latest values, visible window
High-resolution chart · PNG
GMED r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 12.9743% | |
| 32.049% | |
| 69.8418% | |
| -24.9944% | |
| 15.1765% | |
| 40.6938% | |
| 8.2474% | |
| 27.0542% | |
| -1.9155% | |
| 22.6371% | |
| 16.5116% | |
| 15.9881% | |
| -3.7814% | |
| 19.0164% | |
| 10.1131% | |
| 3.84% | |
| 0% |